MDI-2268
MDI-2268 is an inhibitor of plasma kallikrein inhibitor 1 (PAI-1) . MDI-2268 has good antithrombotic properties and regulates blood coagulation and fibrinolysis process by enhancing fibrinolysis. MDI-2268 can be used in research areas such as deep vein thrombosis[1].
Product Specifications
CAS Number
1609176-50-2
UNSPSC
12352005
Target
Apoptosis; PAI-1
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/mdi-2268.html
Concentration
10mM
Purity
99.73
Solubility
DMSO : 166.67 mg/mL (ultrasonic)
Smiles
O=C(NN)C(NCC1=CC=CC(OC(F)(F)F)=C1)=O
Molecular Formula
C10H10F3N3O3
Molecular Weight
277.20
References & Citations
[1]Gordon A, et al. Natural History of Stasis-Induced Deep Venous Thrombosis in a Murine Model and Application in the Clinical Setting: A Histochemical Approach[J]. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2020, 8 (2) : 309.|[2]Sun S, et al., Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction. Sci Immunol. 2024 Nov 8;9 (101) :eadi7907.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY424010 100 µg
GTF2IRD2B (NM_001003795) Human Over-expression Lysate
Sign In for Pricing
View Details 